Gerard C. Blobe
Duke University
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
TGF-β signaling in diseases
Strong evidence · 2 supporting papers · latest 2026
Colorectal Cancer Treatments and Studies
Solid evidence · 1 supporting paper · latest 2026
Cancer Immunotherapy and Biomarkers
Supporting evidence · 1 supporting paper · latest 2026
Cancer Genomics and Diagnostics
Supporting evidence · 1 supporting paper · latest 2026
Genomics and Rare Diseases
Supporting evidence · 1 supporting paper · latest 2026
Growth Hormone and Insulin-like Growth Factors
Supporting evidence · 1 supporting paper · latest 2026
Galectins and Cancer Biology
Supporting evidence · 1 supporting paper · latest 2025
Glycosylation and Glycoproteins Research
Supporting evidence · 1 supporting paper · latest 2025
Publications (3)
Loss of ALK4 promotes cancer progression through regulating TGF-β receptor N-glycosylation
2025DOI
Human PRSS8 functions as a targetable, endogenous TGFBR3 sheddase via the novel cholesterol-PRSS8-TGF-β axis
2026DOI
Abstract CT184: Preliminary results of first-line botensilimab (BOT) and balstilimab (BAL) optimization in microsatellite stable colorectal cancer (MSS CRC) without liver, bone, or brain metastasis (BBOpCo)
2026DOI
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Duke University
Source: ScienceWe Extractor · retrieved 2026-09-27